Putnam Global Health Care Fund

Scorecard
1 / 5 Stars
Lipper
1 1 5 1 1
Zacks Investment Research
4 (Sell)
Standard & Poor's
3 / 5 Stars
TheStreet.com
B (Buy)

U.S. News evaluated 33 Health Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all Putnam funds

See full Health rankings

See more fund rankings

Performance

The fund has returned 33.05 percent over the past year, 18.90 percent over the past three years, 17.16 percent over the past five years, and 9.03 percent over the past decade.

Trailing Returns Updated 06.30.2014
Year to date 11.9%
1 Year 33.1%
3 Years (Annualized) 18.9%
5 Years (Annualized) 17.2%
10 Years (Annualized) 9.0%

See more PHLMX performance

Summary

The investment seeks capital appreciation. The fund invests mainly in common stocks (growth or value stocks or both) of large and midsize companies worldwide that the manager believes have favorable investment potential. Potential investments include companies that manufacture health care supplies or provide health care-related services, and companies in the research, development, production and marketing of pharmaceuticals and biotechnology products. It may also use derivatives, and may engage in short sales of securities. The fund is non-diversified.

Fees

Fees are Low compared to funds in the same category.
Putnam Global Health Care Fund has an expense ratio of 1.71 percent.

See more PHLMX fees

Risk

Risk is Average compared to funds in the same category according to Morningstar.

See more PHLMX risk